Six technologies developed at Vanderbilt University earned U.S. patent protection in October. They are:
|
|
8,865,725
|
|
Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptors
|
|
|
8,865,130
|
|
Methods and compositions for diagnostic and therapeutic targeting of COX-2
|
|
|
8,861,311
|
|
System and method for estimating projectile trajectory and source location
|
|
|
8,853,392
|
|
Benzamide mGluR5 positive allosteric modulators and methods of making and using same
|
|
|
8,853,274
|
|
Compositions and methods for targeting glioblastomas cells
|
|
|
8,853,237
|
|
Naphthyridinone analogs as mGluR5 positive allosteric modulators
|
